FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AZILECT (rasagiline) from Teva Neuroscience, Inc., authorizing changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

SUPPL AP for AZILECT (RASAGILINE MESYLATE)